Ocular Therapeutix SG&A Expense (Quarterly) Insights

Ocular Therapeutix Inc (OCUL)

6.16 +0.30 (+5.03%) USD | NASDAQ | May 03, 09:34

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	17.27M
September 30, 2023	17.90M
June 30, 2023	19.36M
March 31, 2023	19.96M
December 31, 2022	18.88M
September 30, 2022	18.72M
June 30, 2022	17.93M
March 31, 2022	16.62M
December 31, 2021	16.67M
September 30, 2021	17.65M
June 30, 2021	16.99M
March 31, 2021	15.75M
December 31, 2020	13.39M
September 30, 2020	12.48M
June 30, 2020	11.30M
March 31, 2020	12.31M
December 31, 2019	12.69M
September 30, 2019	12.93M
June 30, 2019	12.28M
March 31, 2019	8.705M
December 31, 2018	7.412M
September 30, 2018	5.514M

Date	Value
June 30, 2018	5.314M
March 31, 2018	5.488M
December 31, 2017	5.182M
September 30, 2017	7.468M
June 30, 2017	10.56M
March 31, 2017	9.303M
December 31, 2016	5.528M
September 30, 2016	3.917M
June 30, 2016	4.465M
March 31, 2016	3.795M
December 31, 2015	3.733M
September 30, 2015	3.249M
June 30, 2015	3.271M
March 31, 2015	2.764M
December 31, 2014	2.874M
September 30, 2014	2.405M
June 30, 2014	1.731M
March 31, 2014	1.885M
December 31, 2013	0.577M
September 30, 2013	0.651M
June 30, 2013	0.585M
March 31, 2013	0.573M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

11.30M

Minimum

Jun 2020

19.96M

Maximum

Mar 2023

15.85M

Average

16.67M

Median

Dec 2021

SG&A Expense (Quarterly) Benchmarks